Fiscal period ending 2025-12-31 versus 2024-12-31
— view filing on EDGAR →
A newly disclosed 10% revenue concentration in a single bottler relationship — compounded by reputational exposure to that partner's actions — is the sharpest incremental risk, but it lands alongside concrete regulatory escalation (childhood nutrition policy, SNAP restriction risk) and a materially broadened product-recall liability profile. Together, the three changes represent a real, substantive worsening across customer concentration, regulatory, and operational dimensions, though no solvency or existential trigger is present.
3 company-specific
Company-specific changes
Revised
Added disclosure of 10% revenue concentration with single bottler and expanded risk scope to include reputational/brand damage from bottler actions.
RISKS RELATED TO THE COCA-COLA SYSTEM We rely on our bottling partners for a significant portion of our business. If we are unable to maintain good relationships with our bottling partners, our…
Revised
Added specific disclosure of government focus on childhood chronic diseases and new risk of SNAP restrictions—concrete regulatory threats beyond prior boilerplate.
RISKS RELATED TO CONSUMER DEMAND FOR OUR PRODUCTS Obesity and other health-related concerns may reduce demand for some of our products. There is ongoing concern among consumers, public health…
Revised
Expanded scope of recall triggers (undeclared allergens, misbranding, spoilage explicitly added), broader liability exposure, and new risk of production disruption from remediation efforts.
Product safety and quality concerns could negatively affect our business. Our success depends in large part on our ability to maintain consumer confidence in the safety and quality of all of our…